Local and Global News
THOUSAND OAKS, Calif., March 23, 2020-Amgen and the Amgen Foundation today announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic.
Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections.
Regenerative medicine is fascinating business. BioTechCanada is asking you to answer the call for the AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020!
See details & requirements for proposals and apply now at www.bionation.ca
Life Sciences Innovation Hub Members and Tenants can access up to 100 hours of free consultancy from a talented roster of 25 Expert Advisors located across Canada and parts of the U.S.